Showing 1,161 - 1,180 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.04s Refine Results
  1. 1161
  2. 1162
  3. 1163
  4. 1164

    Decreased Integrity, Content, and Increased Transcript Level of Mitochondrial DNA Are Associated with Keratoconus by Xiao-Dan Hao (215742)

    Published 2016
    “…The relative mtDNA content of KC corneas was significantly lower than that of normal corneas (<i>P</i> = 9.19×10<sup>−24</sup>), possibly due to decreased expression of the mitochondrial transcription factor A (<i>TFAM</i>) gene (<i>P</i> = 3.26×10<sup>−3</sup>). …”
  5. 1165
  6. 1166
  7. 1167
  8. 1168
  9. 1169
  10. 1170

    Effects of A1AR expression on response to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

    Published 2013
    “…<p>A: At E9.5, responses to hypoxia in A1AR −/− (n = 15) and A1AR +/− (n = 50) embryos were studied. …”
  11. 1171
  12. 1172

    Percent positivity of HPV16 variant by 5-year age intervals. by Ana Alfaro (280118)

    Published 2016
    “…<p>The figure shows the percentage of HPV16 infections as a whole and as segregated by lineages D (D2 and D3) and A (A1/2) based on 5-year age intervals for all CC patients (n = 462). …”
  13. 1173
  14. 1174
  15. 1175
  16. 1176

    (A) The proportion of fast MyHC myotubes is decreased in Igf-2 deficient mice (maternal disomy Chromosome 7 - MatDi) at E14 by Deborah Merrick (54928)

    Published 2011
    “…(B) Embryo immunoblotting for Igf-2 demonstrates a stage related increase in Igf-2 protein between E10.5 and E15.5 in WT and absence of Igf-2 in MatDi embryos at E14.5 and E15.5 Tracks 1–4 E10.5, E13.5, E14.5 and E15.5 WT embryos respectively, Track 5 E14.5 MatDi, Track 6 E15.5 MatDi and Track 7 E15.5 WT. …”
  17. 1177
  18. 1178

    Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

    Published 2017
    “…Pretreatment with bortezomib (50–250 nM, 2–7 h) significantly decreased transport of [<sup>3</sup>H]CCK-8, a specific OATP1B3 substrate, in HEK293-OATP1B3 and human sandwich-cultured hepatocytes (SCH). …”
  19. 1179
  20. 1180